Joseph M. Giaconia

2.0k total citations
14 papers, 1.6k citations indexed

About

Joseph M. Giaconia is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Joseph M. Giaconia has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Surgery. Recurrent topics in Joseph M. Giaconia's work include Diabetes Treatment and Management (6 papers), Prostate Cancer Treatment and Research (6 papers) and Diabetes Management and Research (6 papers). Joseph M. Giaconia is often cited by papers focused on Diabetes Treatment and Management (6 papers), Prostate Cancer Treatment and Research (6 papers) and Diabetes Management and Research (6 papers). Joseph M. Giaconia collaborates with scholars based in United States, Singapore and Türkiye. Joseph M. Giaconia's co-authors include Theresa P. Pretlow, Stuart Schwartz, James W. Jacobberger, Byron J. Hoogwerf, Thomas G. Pretlow, Man‐Sun Sy, Johng S. Rhim, R. Michael Sramkoski, Desheng Zhang and Susan Ruth Marengo and has published in prestigious journals such as Annals of Internal Medicine, JNCI Journal of the National Cancer Institute and Diabetic Medicine.

In The Last Decade

Joseph M. Giaconia

14 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph M. Giaconia United States 11 801 629 619 264 262 14 1.6k
Takehiko Segawa Japan 18 600 0.7× 642 1.0× 231 0.4× 144 0.5× 190 0.7× 61 1.3k
Yuanjie Niu China 21 729 0.9× 748 1.2× 158 0.3× 87 0.3× 306 1.2× 41 1.4k
Antonio Matrone Italy 25 544 0.7× 153 0.2× 1.1k 1.9× 436 1.7× 397 1.5× 92 1.8k
Alykhan Motani United States 13 764 1.0× 116 0.2× 185 0.3× 293 1.1× 124 0.5× 18 1.5k
Lynn N. Thomas Canada 18 424 0.5× 792 1.3× 555 0.9× 53 0.2× 75 0.3× 31 1.3k
Chellappagounder Thangavel United States 20 621 0.8× 702 1.1× 199 0.3× 55 0.2× 850 3.2× 42 1.7k
Mirosław Kozłowski Poland 23 819 1.0× 626 1.0× 71 0.1× 314 1.2× 661 2.5× 83 1.9k
Yongde Liao China 18 453 0.6× 425 0.7× 99 0.2× 113 0.4× 317 1.2× 75 1.1k
Yasuko Nishizawa Japan 19 444 0.6× 201 0.3× 126 0.2× 102 0.4× 233 0.9× 53 1.1k
Alicia J. Allred United States 18 665 0.8× 114 0.2× 381 0.6× 79 0.3× 528 2.0× 27 1.4k

Countries citing papers authored by Joseph M. Giaconia

Since Specialization
Citations

This map shows the geographic impact of Joseph M. Giaconia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Giaconia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Giaconia more than expected).

Fields of papers citing papers by Joseph M. Giaconia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Giaconia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Giaconia. The network helps show where Joseph M. Giaconia may publish in the future.

Co-authorship network of co-authors of Joseph M. Giaconia

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M. Giaconia. A scholar is included among the top collaborators of Joseph M. Giaconia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M. Giaconia. Joseph M. Giaconia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Oğuz, Aytekin, et al.. (2013). Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study. Current Medical Research and Opinion. 29(8). 911–920. 25 indexed citations
3.
Tanenberg, Robert J., David B. Clemow, Joseph M. Giaconia, & Richard C. Risser. (2013). Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis. Pain Practice. 14(7). 640–648. 18 indexed citations
4.
Pīrāgs, Valdis, Mariusz Dąbrowski, Mustafa Sait Gönen, et al.. (2012). Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings. International Journal of Clinical Practice. 66(11). 1033–1041. 5 indexed citations
5.
Chacra, Antônio Roberto, Mark Kipnes, Liza L. Ilag, et al.. (2010). Comparison of insulin lispro protamine suspension and insulin detemir in basal‐bolus therapy in patients with Type 1 diabetes. Diabetic Medicine. 27(5). 563–569. 8 indexed citations
6.
Gill, Anne, Byron J. Hoogwerf, Simon Bruce, et al.. (2010). Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study. Cardiovascular Diabetology. 9(1). 6–6. 117 indexed citations
7.
Zinman, Bernard, Byron J. Hoogwerf, Santiago Durán García, et al.. (2007). The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes. Annals of Internal Medicine. 146(7). 477–485. 360 indexed citations
8.
Chintalacharuvu, Subba R., et al.. (2005). An essential role for CCL3 in the development of collagen antibody-induced arthritis. Immunology Letters. 100(2). 202–204. 33 indexed citations
9.
Pretlow, Thomas G., Stuart Schwartz, Joseph M. Giaconia, et al.. (2000). Prostate cancer and other xenografts from cells in peripheral blood of patients.. PubMed. 60(15). 4033–6. 32 indexed citations
10.
Depinet, Theresa W., et al.. (1999). Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors. The Prostate. 41(1). 7–11. 11 indexed citations
11.
Sramkoski, R. Michael, Thomas G. Pretlow, Joseph M. Giaconia, et al.. (1999). A new human prostate carcinoma cell line, 22Rv1. In Vitro Cellular & Developmental Biology - Animal. 35(7). 403–409. 461 indexed citations
12.
Nagabhushan, M., Charles M. Miller, Theresa P. Pretlow, et al.. (1996). CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar.. PubMed. 56(13). 3042–6. 207 indexed citations
13.
Wainstein, Mark A., Fei He, Dan R. Robinson, et al.. (1994). CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma.. PubMed. 54(23). 6049–52. 190 indexed citations
14.
Pretlow, T G, S R Wolman, Mark A. Micale, et al.. (1993). Xenografts of Primary Human Prostatic Carcinoma. JNCI Journal of the National Cancer Institute. 85(5). 394–398. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026